Prognostic Role of Circulating Tumor Cells in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Cabazitaxel: A Prospective Biomarker Study.
Filippos KoinisZafeiris ZafeiriouIppokratis MessaritakisPanagiotis KatsaounisAnna KoumarianouEmmanouil KontopodisEvangelia ChantzaraChrissovalantis AidarinisAlexandros LazarouGeorge ChristodoulopoulosChristos EmmanouilidesDora HatzidakiGalatea KallergiVassilis GeorgouliasAthanasios ΚotsakisPublished in: Cancers (2023)
In patients with mCRPC treated with cabazitaxel, CTC counts both at baseline and after the first cycle retain their prognostic significance, implying that liquid biopsy monitoring might serve as a valuable tool for predicting treatment efficacy and survival outcomes.